NCT04960345

Brief Summary

This is a a prospective cohort study. According to the inclusion criteria, volunteers were recruited from patients undergoing total knee arthroplasty. The patients are devided into two groups: the conventional TKA,the computer-assisted surgery(CAS) using Brainlab Knee 3 system.The differences of postoperative alignment,operative time,blood loss will be studied between the two groups.Clinical and functional evaluation using the scoring system of HSS(Hospital for Special Surgery) score, Western Ontario and McMaster University osteoarthritis index (WOMAC), Forgotten joint score(FJS-12) will be compared between the 2 groups,after surgery, and at the follow-up of 3 months、6 months and 12 months.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
188

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2022

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 4, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 13, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

January 1, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

July 13, 2021

Status Verified

July 1, 2021

Enrollment Period

12 months

First QC Date

July 4, 2021

Last Update Submit

July 4, 2021

Conditions

Keywords

Total knee arthroplastyLower limb alignmentNavigationFunctional outcomes

Outcome Measures

Primary Outcomes (1)

  • lower limb alignment

    knee-ankle angle (HKA) and components placement using coronal femoral-component angle (CFA) and coronal tibia- component angle (CTA)、sagittal femoral-component angle (SFA) and sagittal tibia-component angle(STA).

    Within 1 week after surgery

Secondary Outcomes (5)

  • Operation time

    Immediately after surgery

  • Blood loss

    3 days after surgery

  • the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    3 months、6 months and 12 months after surgery

  • HSS(Hospital for Special Surgery) score

    6 months and 12 months after surgery

  • Forgotten Joint Score-12 (FJS-12)

    6 months and 12 months after surgery

Study Arms (2)

The traditional group

The traditional group underwent prosthesis placement using traditional intramedullary positioning method.

The navigation group

The navigation group performed surgery using the Brainlab Knee 3 navigation system.Informed consent was signed after grouping.

Device: Brainlab Knee 3

Interventions

Brainlab knee 3 navigation system is a kind of imageless computer-assisted navigation system.

Also known as: Brainlab knee 3 navigation system
The navigation group

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with knee osteoarthritis who underwent primary TKA

You may qualify if:

  • Patients with knee osteoarthritis who underwent primary TKA;
  • Informed consent has been signed and medical records are complete;
  • No severe varus or valgus deformity of the knee (\< 20°).

You may not qualify if:

  • Patients undergoing revision knee replacement;
  • patients with rheumatoid arthritis and secondary knee osteoarthritis;
  • Patients with severe valgus deformity(≥ 20°);
  • Taking anticoagulant drugs for a long time in the past, or suffering from the following diseases: Renal insufficiency, liver insufficiency, severe heart disease (or coronary stent implantation within the last 12 months), severe respiratory disease, history of deep vein thrombosis in the lower extremities or a high risk of thrombosis (hereditary/acquired thrombosis), coagulation dysfunction, stroke, and malignancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2021

First Posted

July 13, 2021

Study Start

January 1, 2022

Primary Completion

December 31, 2022

Study Completion

December 31, 2023

Last Updated

July 13, 2021

Record last verified: 2021-07